Location: New York, NY
CIK: 0001534261 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value: $1.503B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| WGS | GENEDX HOLDINGS CORP | 3,507,164 | $270M | 17.9% | $9.11 | +666.5% | COM CL A | 81663L200 |
| BLFS | BIOLIFE SOLUTIONS INC | 8,707,165 | $226M | 15.0% | $19.43 | +28.1% | COM NEW | 09062W204 |
| RVMD | REVOLUTION MEDICINES INC | 3,699,283 | $162M | 10.8% | $25.89 | +94.9% | COM | 76155X100 |
| SRPT | SAREPTA THERAPEUTICS INC | 1,073,500 | $131M | 8.7% | $100.84 | +21.5% | COM | 803607100 |
| LAB | STANDARD BIOTOOLS INC | 71,254,677 | $125M | 8.3% | $2.36 | -21.1% | COM | 34385P108 |
| ILMN | ILLUMINA INC | 750,000 | $100M | 6.7% | $119.44 | +19.2% | COM | 452327109 |
| RNAM | AVIDITY BIOSCIENCES INC | 2,045,000 | $59.47M | 4.0% | $14.11 | +196.3% | COM | 05370A108 |
| CDXS | CODEXIS INC | 8,100,000 | $38.64M | 2.6% | $2.87 | +43.7% | COM | 192005106 |
| RLAY | RELAY THERAPEUTICS INC | 8,948,574 | $36.87M | 2.5% | $19.94 | -72.7% | COM | 75943R102 |
| EXAS | EXACT SCIENCES CORP | 650,000 | $36.52M | 2.4% | $74.77 | -16.8% | COM | 30063P105 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 140,000 | $32.94M | 2.2% | $138.08 | +90.5% | COM | 02043Q107 |
| BEAM | BEAM THERAPEUTICS INC | 1,250,000 | $31M | 2.1% | $40.28 | -36.6% | COM | 07373V105 |
| NGNE | NEUROGENE INC | 1,295,361 | $29.61M | 2.0% | $27.94 | +33.2% | COM | 64135M105 |
| — | BLUEPRINT MEDICINES CORP | 326,378 | $28.47M | 1.9% | $3820.05 | — | COM | 09627Y109 |
| NTLA | INTELLIA THERAPEUTICS INC | 2,000,000 | $23.32M | 1.6% | $37.51 | -58.4% | COM | 45826J105 |
| — | VERVE THERAPEUTICS INC | 3,995,571 | $22.54M | 1.5% | $36.00 | — | COM | 92539P101 |
| DNLI | DENALI THERAPEUTICS INC | 990,000 | $20.18M | 1.3% | $29.48 | -13.2% | COM | 24823R105 |
| GPCR | STRUCTURE THERAPEUTICS INC | 700,000 | $18.98M | 1.3% | $33.80 | — | SPONSORED ADS | 86366E106 |
| SEPN | SEPTERNA INC | 553,268 | $12.67M | 0.8% | $23.65 | 0.0% | COM | 81734D104 |
| VCYT | VERACYTE INC | 276,308 | $10.94M | 0.7% | $24.40 | +55.2% | COM | 92337F107 |
| GH | GUARDANT HEALTH INC | 350,000 | $10.69M | 0.7% | $26.87 | +4.7% | COM | 40131M109 |
| TNYA | TENAYA THERAPEUTICS INC | 6,732,971 | $9.628M | 0.6% | $12.86 | -82.6% | COM | 87990A106 |
| AGIO | AGIOS PHARMACEUTICALS INC | 250,000 | $8.215M | 0.5% | $46.98 | 0.0% | COM | 00847X104 |
| MRNA | MODERNA INC | 175,000 | $7.277M | 0.5% | $47.80 | 0.0% | COM | 60770K107 |
| MRNA | MODERNA INC | 175,000 | $7.277M | 0.5% | $47.80 | 0.0% | Call | 60770K107 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 1,150,000 | $6.405M | 0.4% | $16.94 | -53.7% | COM | 35104E100 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 475,000 | $6.279M | 0.4% | $18.99 | -9.9% | COM | 87164F105 |
| — | 2SEVENTY BIO INC | 2,000,000 | $5.88M | 0.4% | $9.15 | — | COMMON STOCK | 901384107 |
| IPSC | CENTURY THERAPEUTICS INC | 5,190,506 | $5.242M | 0.3% | $10.97 | -87.6% | COM | 15673T100 |
| FTRE | FORTREA HLDGS INC | 275,000 | $5.129M | 0.3% | $19.49 | 0.0% | COMMON STOCK | 34965K107 |
| CTNM | CONTINEUM THERAPEUTICS INC | 296,666 | $4.346M | 0.3% | $16.10 | -1.7% | CL A | 21217B100 |
| TNGX | TANGO THERAPEUTICS INC | 1,188,349 | $3.672M | 0.2% | $5.87 | -20.9% | COM | 87583X109 |
| ABSI | ABSCI CORPORATION | 973,260 | $2.55M | 0.2% | $19.41 | -81.9% | COM | 00091E109 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 1,035,859 | $1.896M | 0.1% | $11.43 | -82.9% | COM | 69404D108 |
| RXRX | RECURSION PHARMACEUTICALS IN | 165,323 | $1.118M | 0.1% | $6.72 | 0.0% | CL A | 75629V104 |
| PRME | PRIME MEDICINE INC | 367,175 | $1.072M | 0.1% | $18.06 | -80.6% | COM | 74168J101 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 86,014 | $597K | 0.0% | $20.37 | -63.2% | COM | 61225M102 |
| DNA | GINKGO BIOWORKS HOLDINGS INC | 36,493 | $358K | 0.0% | $10.02 | -14.5% | CL A NEW | 37611X209 |
| — | KRONOS BIO INC | 123,839 | $118K | 0.0% | $29.87 | — | COM | 50107A104 |